Evidence map›Paper›PMID 35763278›Full record

ReviewActa otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale2022

COVID-19 and head and neck cancer management. Experience of an oncological hub comprehensive cancer centre and literature review.

Francesco Chu, Jacopo Zocchi, Rita De Berardinis, Francesco Bandi, Giacomo Pietrobon, Donatella Scaglione, Davide Radice, Marta Tagliabue, Mohssen Ansarin

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Francesco ChuDepartment of Otorhinolaryngology and Head and Neck Surgery, European Institute of Oncology IRCCS, Milan, Italy.
Jacopo ZocchiDepartment of Otorhinolaryngology and Head and Neck Surgery, European Institute of Oncology IRCCS, Milan, Italy.
Rita De BerardinisDepartment of Otorhinolaryngology and Head and Neck Surgery, European Institute of Oncology IRCCS, Milan, Italy.
Francesco BandiDepartment of Otorhinolaryngology and Head and Neck Surgery, European Institute of Oncology IRCCS, Milan, Italy.
Giacomo PietrobonDepartment of Otorhinolaryngology and Head and Neck Surgery, European Institute of Oncology IRCCS, Milan, Italy.
Donatella ScaglioneTrial Management and Data Management, Clinical Trial Office, Scientific Direction, European Institute of Oncology IRCCS, Milan, Italy.
Davide RadiceDivision of Epidemiology and Biostatistics, European Institute of Oncology IRCCS, Milan, Italy.
Marta TagliabueDepartment of Otorhinolaryngology and Head and Neck Surgery, European Institute of Oncology IRCCS, Milan, Italy.
Mohssen AnsarinDepartment of Otorhinolaryngology and Head and Neck Surgery, European Institute of Oncology IRCCS, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Head and Neck NeoplasmsHumansCOVID-19delayhead and neck canceroncological hubtreatment

Identifiers

PMID35763278
PMCPMC9137385

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.